Discure is developing the first curative solution for disc degeneration. Its breakthrough-designated implantable bioelectronic platform actively restores and controls fluid, oxygen, and nutrient flow into degenerated discs – addressing the root cause of disease. Unlike existing treatments that only mask symptoms, Discure aims to reverse disease progression and preserve natural spinal function. The platform is designed to extend to additional spinal pathologies and osteoarthritis-related disorders of synovial joints.